Treatment of Pain with Antidepressants

Q Medicine
B. Kerr, Curtis A. Benson, Katherine A. Mifflin, S. Jesudasan, S. Dursun, G. Baker
{"title":"Treatment of Pain with Antidepressants","authors":"B. Kerr, Curtis A. Benson, Katherine A. Mifflin, S. Jesudasan, S. Dursun, G. Baker","doi":"10.5455/BCP.20150825014707","DOIUrl":null,"url":null,"abstract":"INTRODUCTION Chronic pain can result in impairments in quality of life, mood, sleep and cognition 1-5. A high degree of comorbidity often exists between chronic pain and psychiatric disorders, including depression and anxiety, and the coexistence of depression and chronic pain may result in increased difficulties in treating both conditions 5-9. In the relationship between depression and pain, it appears that one can influence the development of the other, i.e., major depression can be a strong predictor of subsequently developing pain and vice versa 9. There is still considerable uncertainty about the reasons for the co-occurrence of pain and depression, although this is an active area of research 5,10-12. Patients experiencing chronic pain are often treated with antidepressants 13-18. Most of the antidepressants produce increased functional availability of the biogenic amines noradrenaline (NA) and/or 5-hydroxytryptamine (5-HT, serotonin) 19,20 , and there is now considerable evidence also implicating GABAergic and glutamatergic mechanisms in the antidepressant effects of these drugs 21-23. Interestingly, these four neurotransmitter systems also appear to be involved in the development and/or modulation of pain 24-30 , suggesting common mechanisms for the development of depression and chronic pain. However, while selective serotonin reuptake inhibitor antidepressants (SSRIs) are used frequently in treatment of depression, they are not as effective as tricyclic antidepressants (TCAs) or serotonin-noradrenaline reuptake inhibitor antidepressants (SNRIs) for most chronic pain conditions 9,14,15,31. Since monoaminergic systems are involved in both depression and chronic pain, it is not surprising that antidepressants have been used frequently for treating chronic pain. However, it should also be noted that many antidepressants have a true analgesic effect in that they are effective at reducing pain in people without depression 5,10,13,14. Pain conditions in which antidepressants are used for treatment include irritable bowel syndrome, central pain syndrome, arthritis, fibromyalgia, low back pain, migraine, d i a b e t i c n e u r o p a t h y, c h e m o-i n d u c e d neuropathies and postherpetic neuralgia (shingles-associated pain) 5,10,14,16,17. Often these pain conditions are treated with TCAs, which are inhibitors of the reuptake of NA and 5-HT. The relative lack of responsiveness to SSRIs and relative success of TCAs in many chronic pain patients suggest that noradrenergic pathways may be more important in chronic pain than in major depressive disorder. The SNRIs are also reported to be more effective than SSRIs in the management …","PeriodicalId":17852,"journal":{"name":"Klinik Psikofarmakoloji Bulteni-bulletin of Clinical Psychopharmacology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Klinik Psikofarmakoloji Bulteni-bulletin of Clinical Psychopharmacology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.5455/BCP.20150825014707","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

INTRODUCTION Chronic pain can result in impairments in quality of life, mood, sleep and cognition 1-5. A high degree of comorbidity often exists between chronic pain and psychiatric disorders, including depression and anxiety, and the coexistence of depression and chronic pain may result in increased difficulties in treating both conditions 5-9. In the relationship between depression and pain, it appears that one can influence the development of the other, i.e., major depression can be a strong predictor of subsequently developing pain and vice versa 9. There is still considerable uncertainty about the reasons for the co-occurrence of pain and depression, although this is an active area of research 5,10-12. Patients experiencing chronic pain are often treated with antidepressants 13-18. Most of the antidepressants produce increased functional availability of the biogenic amines noradrenaline (NA) and/or 5-hydroxytryptamine (5-HT, serotonin) 19,20 , and there is now considerable evidence also implicating GABAergic and glutamatergic mechanisms in the antidepressant effects of these drugs 21-23. Interestingly, these four neurotransmitter systems also appear to be involved in the development and/or modulation of pain 24-30 , suggesting common mechanisms for the development of depression and chronic pain. However, while selective serotonin reuptake inhibitor antidepressants (SSRIs) are used frequently in treatment of depression, they are not as effective as tricyclic antidepressants (TCAs) or serotonin-noradrenaline reuptake inhibitor antidepressants (SNRIs) for most chronic pain conditions 9,14,15,31. Since monoaminergic systems are involved in both depression and chronic pain, it is not surprising that antidepressants have been used frequently for treating chronic pain. However, it should also be noted that many antidepressants have a true analgesic effect in that they are effective at reducing pain in people without depression 5,10,13,14. Pain conditions in which antidepressants are used for treatment include irritable bowel syndrome, central pain syndrome, arthritis, fibromyalgia, low back pain, migraine, d i a b e t i c n e u r o p a t h y, c h e m o-i n d u c e d neuropathies and postherpetic neuralgia (shingles-associated pain) 5,10,14,16,17. Often these pain conditions are treated with TCAs, which are inhibitors of the reuptake of NA and 5-HT. The relative lack of responsiveness to SSRIs and relative success of TCAs in many chronic pain patients suggest that noradrenergic pathways may be more important in chronic pain than in major depressive disorder. The SNRIs are also reported to be more effective than SSRIs in the management …
用抗抑郁药治疗疼痛
慢性疼痛可导致生活质量、情绪、睡眠和认知能力的损害1-5。慢性疼痛和精神疾病(包括抑郁和焦虑)之间通常存在高度的共病,抑郁和慢性疼痛的共存可能导致治疗这两种疾病的难度增加5-9。在抑郁和疼痛之间的关系中,似乎一方可以影响另一方的发展,也就是说,重度抑郁可能是随后发展为疼痛的一个强有力的预测因素,反之亦然。尽管这是一个活跃的研究领域,但关于疼痛和抑郁共存的原因仍有相当大的不确定性。患有慢性疼痛的患者通常用抗抑郁药治疗。大多数抗抑郁药可增加生物胺去甲肾上腺素(NA)和/或5-羟色胺(5-HT, 5-羟色胺)的功能可用性19,20,现在也有相当多的证据表明这些药物的抗抑郁作用的gaba能和谷氨酸能机制21-23。有趣的是,这四种神经递质系统似乎也参与了疼痛的发展和/或调节,这表明抑郁症和慢性疼痛的发展有共同的机制。然而,虽然选择性5 -羟色胺再摄取抑制剂(SSRIs)经常用于治疗抑郁症,但对于大多数慢性疼痛疾病,它们不如三环抗抑郁药(TCAs)或5 -羟色胺-去甲肾上腺素再摄取抑制剂抗抑郁药(SNRIs)有效9,14,15,31。由于单胺能系统与抑郁症和慢性疼痛都有关系,所以抗抑郁药经常被用于治疗慢性疼痛也就不足为奇了。然而,也应该注意到,许多抗抑郁药具有真正的镇痛作用,因为它们对没有抑郁症的人有效地减轻疼痛5,10,13,14。抗抑郁药用于治疗的疼痛疾病包括肠易激综合征、中枢性疼痛综合征、关节炎、纤维肌痛、腰痛、偏头痛和脊髓灰质炎、脊髓灰质炎、脊髓灰质炎、脊髓灰质炎、脊髓灰质炎、脊髓灰质炎、脊髓灰质炎、脊髓灰质炎和脊髓灰质炎、神经病和带状疱疹后神经痛(带状疱疹相关疼痛)5,10,14,16,17。这些疼痛通常用TCAs治疗,TCAs是NA和5-羟色胺再摄取的抑制剂。在许多慢性疼痛患者中,对SSRIs相对缺乏反应和TCAs相对成功表明,去甲肾上腺素能通路在慢性疼痛中可能比在重度抑郁症中更重要。据报道,snri类药物在治疗方面也比ssri类药物更有效。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
0.34
自引率
0.00%
发文量
0
审稿时长
6-12 weeks
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信